-
Zolgensma (AVXS-101) Provisionally Approved
<p style=”text-align: left;”>Zolgensma is provisionally approved by FDA. The company now needs to request approval for market authorization (BLA approval).</p>
https://www.novartis.com/news/media-releases/novartis-highlights-company-transformation-catalyst-rich-pipeline-and-strong-progress-strategy-meet-novartis-management-investor-event